Monoclonal antibody pretargetting techniques... [Nucl Med Commun. 1991] - PubMed

loading

Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody. [Nucl Med Commun. 1988]
Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody.
Pimm MV, Fells HF, Perkins AC, Baldwin RW. Nucl Med Commun. 1988 Nov; 9(11):931-41.
The in vivo uses of streptavidin and biotin: a short progress report. [Nucl Med Commun. 1994]
The in vivo uses of streptavidin and biotin: a short progress report.
Hnatowich DJ. Nucl Med Commun. 1994 Aug; 15(8):575-7.
In situ hybridization using biotinylated probes. An evaluation of different detection systems. [Pathol Res Pract. 1989]
In situ hybridization using biotinylated probes. An evaluation of different detection systems.
Niedobitek G, Finn T, Herbst H, Stein H. Pathol Res Pract. 1989 Mar; 184(3):343-8.
Review Application of avidin-biotin technology to affinity-based separations. [J Chromatogr. 1990]
Review Application of avidin-biotin technology to affinity-based separations.
Bayer EA, Wilchek M. J Chromatogr. 1990 Jun 27; 510:3-11.
Review [The avidin-biotin system. Its application in virology]. [Virologie. 1989]
Review [The avidin-biotin system. Its application in virology].
Popa LM, Kappel D, Marcheş F, Borza B. Virologie. 1989 Jan-Mar; 40(1):43-57.

Review Cancer radioimmunotherapy. [Immunotherapy. 2011]
Review Cancer radioimmunotherapy.
Sharkey RM, Goldenberg DM. Immunotherapy. 2011 Mar; 3(3):349-70.
Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties. [J Biol Chem. 2010]
Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.
Verdoliva A, Bellofiore P, Rivieccio V, Catello S, Colombo M, Albertoni C, Rosi A, Leoni B, Anastasi AM, De Santis R. J Biol Chem. 2010 Mar 19; 285(12):9090-9. Epub 2010 Jan 25.
Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At. [Bioconjug Chem. 2008]
Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At.
Wilbur DS, Hamlin DK, Chyan MK, Brechbiel MW. Bioconjug Chem. 2008 Jan; 19(1):158-70. Epub 2007 Dec 12.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Monoclonal antibody pretargetting techniques for tumour localization: the avidin...
Monoclonal antibody pretargetting techniques for tumour localization: the avidin-biotin system. International Workshop on Techniques for Amplification of Tumour Targetting.
Nucl Med Commun. 1991 Mar ;12(3):211-34.

PubMed
Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytol...
Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytologic and architectural atypia: a clinicopathologic study.
Pathol Oncol Res. 2009 Mar ;15(1):81-8. Epub 2008 Jun 25 .

PubMed
Branched-chain amino acid-enriched supplementation improves insulin resistance i...
Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease.
Int J Mol Med. 2008 Jul ;22(1):105-12.

PubMed
Germline mutation in RNASEL predicts increased risk of head and neck, uterine ce...
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
PLoS One. 2008 Jun 25 ;3(6):e2492.

PubMed
The use of artemisinin-based combination therapies (ACTs) in public secondary he...
The use of artemisinin-based combination therapies (ACTs) in public secondary health facilities in Lagos, Nigeria.
Niger Postgrad Med J. 2008 Jun ;15(2):94-100.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed